← All Lists
supplements · 9 items · 1 min read

9 Key Differences Between Lion's Mane and Bacopa Monnieri for Perimenopause Cognitive Symptoms Before You Choose One

By Rose Malherbe, Editor-in-Chief
Rose
A note from Rose

The number of women who've told me they just grabbed whichever one had better packaging is genuinely heartbreaking — not because either is dangerous, but because the right choice for foggy thinking at 3pm is probably not the right choice for anxiety-driven memory blanks at 2am. This comparison exists because that distinction actually matters.

Learn more about Rose →
When perimenopause brain fog, word-finding failures, and memory slips start disrupting daily life, two supplements consistently come up in the research and in women's conversations: Lion's Mane mushroom and Bacopa monnieri. They are both positioned as brain supporters, but they work through completely different biological pathways, have different evidence profiles in aging women, and suit different symptom pictures. Understanding those differences before choosing one can save a lot of wasted time and money.
1

Primary Mechanism: Nerve Growth vs. Neurotransmitter Modulation

Lion's Mane (Hericium erinaceus) works primarily by stimulating Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF), proteins that support the growth, maintenance, and survival of neurons — a process called neurogenesis. Bacopa monnieri works differently: its active compounds, called bacosides, modulate acetylcholine signalling, reduce oxidative stress in synapses, and influence serotonin and dopamine pathways. This means Lion's Mane is broadly about building and protecting brain architecture, while Bacopa is more about optimising the chemical signals already running through it.

Grade B — Moderate evidence
2

Relevance to Oestrogen Decline: Different Vulnerability Points

During perimenopause, falling oestrogen directly reduces BDNF expression and impairs synaptic plasticity — the brain's ability to form and strengthen connections. Lion's Mane's NGF-stimulating activity targets this exact vulnerability, making it mechanistically interesting for the perimenopausal brain specifically. Bacopa's strength lies in protecting against the oxidative stress and cholinergic dysfunction that tend to accelerate with age, which also worsens as oestrogen declines, but through a parallel rather than directly compensatory route.

Grade B — Moderate evidence
3

Clinical Evidence in Older Adults: Bacopa Has the Longer Track Record

Bacopa monnieri has been studied in randomised controlled trials for cognitive function in adults over 40 for several decades, with multiple meta-analyses confirming improvements in memory acquisition speed, delayed recall, and attention — effects that appear most reliable after 8–12 weeks of consistent use. Lion's Mane has promising human trials, including a well-cited 2009 Japanese RCT showing cognitive improvements in mild cognitive impairment, but the human trial database is smaller and fewer studies have focused specifically on midlife women. Both have genuinely useful evidence, but Bacopa's is more established in terms of volume and replication.

Grade A — Strong evidence
4

Speed of Effect: Lion's Mane Is Slower, Bacopa Is Slower Still

Neither of these supplements works quickly, which is important to set expectations around. Lion's Mane effects on neurotrophic factors can begin measurably within 4 weeks in some studies, though subjective cognitive improvements in human trials often appear around the 8–16 week mark. Bacopa is famously slow — the adaptogenic and memory-consolidation effects that appear in trials typically require 8–12 weeks minimum, with some studies showing continued improvement up to 6 months. Women expecting week-one results from either are likely to abandon both prematurely.

Grade B — Moderate evidence
5

Anxiety and Stress Response: Bacopa Has a Meaningful Adaptogenic Effect

Bacopa monnieri has demonstrated cortisol-reducing and anxiolytic effects in several human trials, making it genuinely useful for the cognitive symptoms that are tangled up with perimenopause anxiety and chronic stress — the kind of brain fog that feels worse on high-pressure days. Lion's Mane has some emerging evidence for mood support, including a small study showing reduced anxiety and depression scores in menopausal women, but it is not classically adaptogenic and its stress-modulating effects are less robust and less replicated. For women whose cognitive symptoms are anxiety-adjacent, Bacopa has a more established dual-action story.

Grade B — Moderate evidence
6

Sleep and Cognitive Recovery: Lion's Mane Shows Emerging Promise

Poor sleep is one of the primary drivers of perimenopause brain fog, and Lion's Mane has emerging evidence — including a 2023 human study — suggesting it may improve sleep quality and reduce sleep-onset issues, possibly through its influence on nerve repair and gut-brain signalling. Bacopa does not have strong direct evidence for improving sleep architecture, though its cortisol-lowering effects may indirectly support sleep in stress-driven insomnia. For women whose cognitive symptoms are clearly downstream of disrupted sleep, Lion's Mane is the more interesting option based on current data.

Grade C — Emerging/anecdotal
7

Gut-Brain Axis: Lion's Mane Has a Unique Gastrointestinal Pathway

Lion's Mane contains beta-glucan polysaccharides that act as prebiotics, supporting gut microbiome diversity — and because the gut-brain axis strongly influences mood, cognition, and neuroinflammation, this represents a secondary mechanism Bacopa simply does not share. Emerging research suggests Lion's Mane may reduce neuroinflammation partly through this gut-brain route, which is particularly relevant given that oestrogen decline is associated with increased gut permeability and neuroinflammatory risk. This makes Lion's Mane a candidate worth considering for women who also experience gut changes alongside their cognitive symptoms in perimenopause.

Grade C — Emerging/anecdotal
8

Side Effect Profiles: Bacopa's Main Issue Is GI Upset, Lion's Mane Rarely Causes Problems

Bacopa monnieri's most commonly reported side effect is gastrointestinal discomfort — nausea, cramping, and loose stools — which affects a meaningful minority of users and is significantly reduced by taking it with food. Lion's Mane is generally very well tolerated, with rare reports of skin itching (possibly related to increased NGF activity) and isolated cases of allergic reaction in people with mushroom allergies. Neither supplement has a serious safety signal in healthy adults at standard doses, but women with mushroom sensitivities should approach Lion's Mane with appropriate caution.

Grade B — Moderate evidence
9

Practical Dosing and Timing: They Follow Different Rules

Bacopa monnieri is typically used at 300–450mg of a standardised extract (45% bacosides) once daily with the largest meal of the day to reduce GI side effects — the fat in food also aids absorption of its fat-soluble active compounds. Lion's Mane is commonly used at 500–1000mg of whole fruiting body extract one to two times daily, and some practitioners suggest morning dosing to align with natural cortisol rhythms, though the evidence base for optimal timing is thin. The practical takeaway is that both require daily consistency over months, not intermittent use, to deliver on their evidence-backed mechanisms.

Grade B — Moderate evidence

Want to go deeper?

Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.

Rose
Meet Rose

Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.

Sharing is caring 💕 If this list helped you feel a little less alone, consider passing Rose along to a friend who might need honest answers too.